U.S. Electric Utilities Stock News

In recent weeks, Silicon Motion Technology has drawn fresh investor attention as analysts projected roughly 44% year-over-year earnings growth for the latest quarter, underpinned by a pattern of earnings and revenue beats and reinforced by upbeat trading in its US-listed ADRs. A key insight is that analysts’ stable or improving estimates, combined with Silicon Motion’s consistent outperformance versus expectations, suggest growing confidence in the company’s ability to convert demand for...

B. Riley Financial, Inc. reported its previously delayed second‑quarter 2025 results, showing revenue of US$225.3 million and net income of US$139.47 million, a sharp swing from a large loss a year earlier, alongside a US$314 million reduction in total debt and timely filing of its Form 10‑Q to meet Nasdaq requirements. Beyond the headline profit rebound, one-off gains from the sale of GlassRatner and senior note exchanges played a central role in the earnings turnaround and helped stabilize...

GeneDx Holdings (WGS) just saw its GUARDIAN newborn genomic screening study highlighted in JAMA’s Research of the Year, a credibility boost that could quietly reshape how investors view its long term growth runway. See our latest analysis for GeneDx Holdings. The recognition has landed while momentum is already strong, with GeneDx’s share price up 76% year to date and an 81% total shareholder return over the last year, signaling investors are steadily repricing its growth story. If this kind...

Patria Investments Limited recently implemented a new corporate structure and created a Global Chief Operating Officer role, appointing Nikitas Psyllakis, formerly of DWS Group, to oversee finance, funds, technology, legal and compliance, risk management, and internal audit, reporting directly to CEO Alex Saigh. This consolidation of core control and support functions under a single global leader may meaningfully influence how efficiently Patria scales its alternatives platform across...

Riot Platforms recently detailed a shift away from its traditional Bitcoin mining focus toward building large-scale AI and high‑performance computing data centers, starting with core‑and‑shell development of two buildings at its Corsicana, Texas campus following land acquisition and campus design completion earlier this year. This move recasts Riot as a power‑rich digital infrastructure developer rather than a pure crypto miner, raising fresh questions about execution, capital intensity, and...

Recent commentary around BWX Technologies (BWXT) has zeroed in on its accelerating Commercial Operations. The Kinectrics integration, microreactor work, and medical isotopes are reinforcing already solid government backed earnings and lifting investor confidence. See our latest analysis for BWX Technologies. The share price has cooled slightly with a 1 month share price return of minus 1.9 percent. However, a powerful year to date share price return of 58.3 percent and a 3 year total...

Thermo Fisher Scientific (TMO) just enrolled the first patient into its new PPD CorEvitas Alzheimer's Disease Registry, a real world data initiative that quietly reinforces the stock's long term healthcare infrastructure story. See our latest analysis for Thermo Fisher Scientific. That backdrop of new registries and high productivity lab platforms lands in a stock that has already logged an 18.4% 90 day share price return and a 25.59% five year total shareholder return, which suggests that...

If you have been wondering whether TechnipFMC is still a smart buy after its huge run, you are not alone. This stock is exactly the kind investors worry they might be late to. Despite a recent dip of 3.5% over the last week, the shares are still up 1.7% over 30 days, 51.2% year to date, 55.7% over the last year and an eye catching 575.0% over five years, which says a lot about how the market view of its prospects has evolved. Part of this momentum reflects growing optimism around offshore...

Certara (CERT) is stepping into 2026 with a leadership reset, as long time CEO Dr. William Feehery exits and former IQVIA executive Jon Resnick takes the helm, reshaping expectations for the stock. See our latest analysis for Certara. The leadership handover seems to have sparked a modest rebound, with a 1 month share price return of 9.41 percent after a tough stretch that left the year to date share price return at negative 14.92 percent and the 5 year total shareholder return at negative...

If you are wondering whether Blackstone Mortgage Trust is still worth buying after its recent run, or if the easy money has already been made, you are not alone. The stock is up 22.6% over the last year and 13.2% year to date, with a strong 9.6% gain in the past month even after a small 1.6% pullback this week. Recent moves have been driven largely by shifting expectations around interest rates and commercial real estate credit risk, as investors reassess which mortgage REITs can navigate...

Perfect (NYSE:PERF) just released a new trend report on how AI is reshaping holiday shopping, showing that nearly 90% of consumers already lean on AI tools to discover products and personalize their experience. See our latest analysis for Perfect. The upbeat reaction to this latest AI shopping report adds a modest boost to Perfect’s recent momentum, with a 1 month share price return of 4.02 percent. However, that sits against a much weaker year to date share price return and a still heavily...

Stephens just kicked off coverage of Apogee Therapeutics (APGE) after highlighting fresh data around its lead drug APG777 in atopic dermatitis, a move that shines a brighter light on the company’s long term pipeline story. See our latest analysis for Apogee Therapeutics. That backdrop helps explain why investors have been leaning in, with Apogee’s 30 day share price return at 21.18 percent, a powerful 90 day share price return of 111.74 percent, and a 1 year total shareholder return of 62.13...

Wondering if Cloudflare is still worth buying after its massive run, or if the stock has already priced in the hype? Let us unpack what the current share price is really implying about its future. Cloudflare is not exactly a quiet name, with the stock up 73.9% year to date and 73.6% over the last year, even after a recent 3.3% dip this week and a roughly flat 30 day move at down 0.3%. These swings have come as investors digest a steady stream of product launches and partnership announcements...

FedEx (FDX) has posted Q2 2026 results with revenue of $23.5 billion and basic EPS of $4.07, anchored by net income of $956 million as the company continues to navigate a steady but measured freight environment. The company has seen revenue move from $21.6 billion in Q3 2025 to $22.0 billion in Q4 2025, $22.2 billion in Q1 2026, and now $23.5 billion in Q2 2026. Basic EPS has ranged from $3.78 to $6.92 over that stretch before landing at $4.07 this quarter, setting up a picture of consistent...

Wondering if Elevance Health is quietly turning into a value opportunity after a rough patch? This article will walk you through whether the current price really makes sense. The stock closed at $340.69 recently and, while it is down 5.1% over the last week and 6.9% year to date, it has climbed 7.7% over the past month and is still up 18.1% over five years, which hints at a recovery story that is still unfolding. Recent headlines around Elevance have focused on its ongoing push into...

In recent days, multiple reports indicated that Intercontinental Exchange, the owner of the New York Stock Exchange, has been in talks to invest in crypto payments firm MoonPay as part of a new funding round that would value MoonPay at about US$5 billion, expanding ICE’s footprint in digital assets and payments infrastructure. This potential investment, alongside ICE’s existing interests in platforms like Bakkt and Polymarket, underlines how the company is building a broader ecosystem around...

If you have been wondering whether Calix is still a buy after its big run up, this breakdown will help you decide if the current price really makes sense or if the upside has already been priced in. The stock is up 1.8% over the last week and 61.3% year to date, while returning 54.7% over the past year, despite being down slightly at -0.3% over the last month and still below its 3 year highs. Investors have been reacting to ongoing momentum in Calix's broadband and cloud platforms, as US...

Molson Coors Beverage (TAP) has been quietly grinding higher, with shares up about 5% over the past month, even as the stock still sits well below where it started the year. See our latest analysis for Molson Coors Beverage. That recent 1 month share price return of just over 5% looks more like a tentative rebound than a full trend change. The share price is still down sharply year to date and longer term total shareholder returns are only modestly positive. If Molson Coors has you...

CVS Health (CVS) has quietly put up a strong run this year, with the stock up roughly 76% year to date and about 83% over the past year, drawing fresh attention from value focused investors. See our latest analysis for CVS Health. That surge in momentum has cooled slightly, with a modest 7 day share price return pullback. However, the year to date share price performance and 1 year total shareholder return still signal a market re rating around CVS Health’s earnings power and cash flow...

Wondering if PTC at about $178 a share is quietly turning into a bargain or if most of the upside is already priced in? You are not the only one trying to make sense of its current valuation. After a choppy year that has left the stock down roughly 5.0% over 12 months and about 2.6% year to date, the recent 1.2% move over the last week and 3.6% over the last month hints that sentiment could be starting to turn. Investors have been digesting a steady stream of updates around PTC's push into...

Zimmer Biomet Holdings, Inc. announced in the past that its Board approved a fourth-quarter 2025 cash dividend of US$0.24 per share, payable on or about January 30, 2026, to stockholders of record as of December 30, 2025. The company also revealed an exclusive collaboration with OneStep to embed smartphone-based gait and mobility analytics into its mymobility Care Management Platform, potentially deepening its role in post-surgery orthopedic recovery and remote monitoring. We’ll now examine...

Grab Holdings (GRAB) just doubled down on automation, buying Chinese robotics startup Infermove while also lifting its 2025 revenue and Adjusted EBITDA guidance, a one-two move that sharpens the stock’s efficiency and profitability story. See our latest analysis for Grab Holdings. That backdrop helps explain why, even with a 1 year total shareholder return of 0.61 percent and a much stronger 3 year total shareholder return of 50.76 percent, the 90 day share price return of negative 22.85...

If you are wondering whether FactSet Research Systems is a bargain or a value trap at around $288 a share, you are not alone. This breakdown is designed to give you a clear answer without the usual jargon. The stock has bounced about 8.1% over the last month after a weak patch. However, with shares still down roughly 39.6% over the past year, the market clearly has mixed feelings about its long term potential and risk. Recent headlines have focused on FactSet expanding its analytics and data...

Earlier this month, The Bank of New York Mellon Corporation said its board elected Charles F. Lowrey as an independent director effective February 15, 2026, while BNY and Google Cloud announced that Gemini Enterprise has been integrated into BNY’s enterprise AI platform, Eliza, to enhance research and automation capabilities. This combination of seasoned board leadership and deeper access to advanced, multimodal AI tools could influence how BNY balances risk management, innovation, and...